Financial analyst predicts Bausch & Lomb (BLCO) could be worth $28/share in a potential takeover, with private equity ...
Inc. BHC gained 14.7% in a week on reports of refinancing its debt to enable the impending sale of its eye care company, Bausch + Lomb BLCO. The industry declined 0.6% during this timeframe. The sale, ...
Gibbons and Venable filed a pair of complaints Wednesday on behalf of Bausch & Lomb involving federal trademark ... Nutriceuticals also sell an eye health dietary supplement called NutriTear ...
6don MSNOpinion
Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical corporate board, ...
Irish Examiner on MSN6d
Bausch + Lomb exploring sale optionsCompany operates a contact lens manufacturing facility in Waterford where approximately 1,500 people are employed.
Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a ...
In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating on Bausch + Lomb Corporation (BLCO – Research ...
(Bloomberg) -- Bausch Health Cos. is working with Jefferies Financial Group to explore refinancing some of its debt to aid a long-planned spinoff of its stake in the eye-care company Bausch + Lomb, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback